CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-29 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −736 | $44.37 | $33K | 21,564 |
| 2023-06-29 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −2,230 | $45.49 | $101K | 19,334 |
| 2023-06-29 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −1,934 | $46.51 | $90K | 17,400 |
| 2023-06-29 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −200 | $47.24 | $9K | 17,200 |
| 2023-06-28 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −2,247 | $49.24 | $111K | 25,153 |
| 2023-06-28 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −1,900 | $50.38 | $96K | 23,253 |
| 2023-06-28 | MacDonald Brian Richard Chief Innovation Officer | Sale 10b5-1 | −953 | $50.80 | $48K | 22,300 |
| 2023-06-28 | Bryce Joanne Chief Financial Officer | Option exercise 10b5-1 | +7,880 | $1.01 | $8K | 11,332 |
| 2023-06-28 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −4,808 | $49.30 | $237K | 6,524 |
| 2023-06-28 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −4,905 | $50.50 | $248K | 1,619 |
| 2023-06-28 | Bryce Joanne Chief Financial Officer | Sale 10b5-1 | −359 | $51.23 | $18K | 1,260 |
| 2023-06-28 | Bryce Joanne Chief Financial Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −7,880 | 526 | ||
| 2023-06-28 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,520 | $49.20 | $75K | 18,805 |
| 2023-06-28 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,300 | $50.00 | $65K | 17,505 |
| 2023-06-28 | Savage William Jacob Chief Medical Officer | Sale 10b5-1 | −1,564 | $50.72 | $79K | 15,941 |
| 2023-06-28 | Novo Holdings A/S 10% owner | Sale | −1,250,000 | $46.10 | $57.6M | 1,090,772 |
| 2023-06-16 | AI DMI LLC 10% owner | Purchase · Warrant (right to buy) | +204,081 | $49.00 | $10.0M | 204,081 |
| 2023-06-09 | Chin Mark Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-06-09 | GEMAYEL GEORGES Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 | ||
| 2023-06-09 | Nicholson Donald William Director | Grant or award · Stock Option (Right to Buy) | +7,136 | 7,136 |
Page 30 of 32 · 639 trades